SUVRETTA CAPITAL MANAGEMENT, LLC purchased 2.6% of their position (46.14K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $539.0K — a small addition. The strongest form of insider conviction signal.
Common stock, par value $0.0001 per share
Shares
+8.70K
Price / share
$11.24
Trade value
$97.79K
% of position
Common stock, par value $0.0001 per share
Shares
+1.51K
Price / share
$11.24
Trade value
$17.03K
% of position
Common stock, par value $0.0001 per share
Shares
+13.95K
Price / share
$11.48
Trade value
$160.15K
% of position
Common stock, par value $0.0001 per share
Shares
+2.43K
Price / share
$11.48
Trade value
$27.94K
% of position
Common stock, par value $0.0001 per share
Shares
+16.65K
Price / share
$12.08
Trade value
$201.13K
% of position
Common stock, par value $0.0001 per share
Shares
+2.89K
Price / share
$12.08
Trade value
$34.94K
% of position
Net shares
+46.14K
Net value
$538.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 12/18/2025 | P · Purchase | +8.70K | $11.24 | $97.79K | 0.1% | 9.54M | 9.55M |
| Common stock, par value $0.0001 per share Indirect | 12/18/2025 | P · Purchase | +1.51K | $11.24 | $17.03K | 0.1% | 1.82M | 1.82M |
| Common stock, par value $0.0001 per share Indirect | 12/19/2025 | P · Purchase | +13.95K | $11.48 | $160.15K | 0.1% | 9.55M | 9.56M |
| Common stock, par value $0.0001 per share Indirect | 12/19/2025 | P · Purchase | +2.43K | $11.48 | $27.94K | 0.1% | 1.82M | 1.82M |
| Common stock, par value $0.0001 per share Indirect | 12/22/2025 | P · Purchase | +16.65K | $12.08 | $201.13K | 0.2% | 9.56M | 9.58M |
| Common stock, par value $0.0001 per share Indirect | 12/22/2025 | P · Purchase | +2.89K | $12.08 | $34.94K | 0.2% | 1.82M | 1.83M |
| Total | +46.14K | $538.97K | ||||||